New Antibiotic Approved: Vabomere
Recently an Intravenous
antibiotic called Vabomere was approved by FDA. It is a combination of
vaborbactam and meropenem. Its indication includes UTIs. This combination will
help us to fight against more serious bacterial infections of the urinary
tract.
The clinical trials were done on
around 550 peoples suffering from complicated UTI. Out of these, 98% of people
were recovered from it. The side effect profile of this combination antibiotic
includes headache and diarrhea. Moreover, allergic reactions at the site of
injection or severe allergic reaction in the body can also be encountered.
It will be effective against a
wide range of bacteria, but to avoid its resistance it should only be used
after a proper culture test against the susceptible bacteria. It will be
manufactured by Rempex Pharmaceuticals (San Diego).
Comments
Post a Comment